OpenVSafe by OpenVAERS
Search V-safe

EJY-17181-74743

2 vaccinations 7 coded responses 15 check-ins 7 free-text entries 6 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
009 / PR
Registered
2021-01-15
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-01-11
    Dose 1 — Moderna
  2. 2021-01-15
    Registered in v-safe
  3. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  4. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Chills, Joint pains
    Adult check-in
  5. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-01-18
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain · Nausea
    Adult check-in
  7. 2021-01-25
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-02-01
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-02-08
    Dose 2 — Moderna
  10. 2021-02-15
    Health check-in — day 7, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches
    Adult check-in
  11. 2021-02-22
    Survey response — day 14, dose 2
    MedDRA: Transient ischaemic attack — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Had a TIA (transient ischemic attack)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-22
    Report sent to call center — day 14, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-03-01
    Survey response — day 21, dose 2
    MedDRA: Transient ischaemic attack — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: T. I. A.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-01
    Report sent to call center — day 21, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2021-03-08
    Survey response — day 28, dose 2
    MedDRA: Transient ischaemic attack — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: TIA
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-03-08
    Report sent to call center — day 28, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2021-03-15
    Survey response — day 35, dose 2
    MedDRA: Neurological symptom — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Post TIA symptoms
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-03-15
    Report sent to call center — day 35, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-03-22
    Survey response — day 42, dose 2
    MedDRA: Asthenia, Disturbance in attention, Dizziness — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Dizziness, weakness, trouble concentrating
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-05-10
    Survey response — 3 months, dose 2
    MedDRA: Fatigue — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Tiredness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-05-10
    Report sent to call center — 3 months, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-06-01
    Call successful
    Participant prefers to complete VAERS report online
  23. 2021-08-09
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  24. 2022-02-08
    Survey response — 12 months, dose 2
    MedDRA: Epstein-Barr virus infection, Fatigue, Optic neuritis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Optic neuritis, Epstein-Barr virus, Chronic fatigue
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-02-08
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  26. 2022-02-10

Vaccinations

DoseDateManufacturerCo-administered
12021-01-11Moderna
22021-02-08Moderna

Call center

6 call center cases

5 successful · 1 unsuccessful

See the call center timeline

Free text

Release 4 — day 14, dose 2

2021-02-22

Symptoms: Had a TIA (transient ischemic attack)

Release 4 — day 21, dose 2

2021-03-01

Symptoms: T. I. A.

Release 5 — day 28, dose 2

2021-03-08

Symptoms: TIA

Release 5 — day 35, dose 2

2021-03-15

Symptoms: Post TIA symptoms

Release 6 — day 42, dose 2

2021-03-22

Symptoms: Dizziness, weakness, trouble concentrating

Release 8 — 3 months, dose 2

2021-05-10

Symptoms: Tiredness

Release 11 — 12 months, dose 2

2022-02-08

Symptoms: Optic neuritis, Epstein-Barr virus, Chronic fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthenia ✓ ✓ ✓
SDDisturbance in attention ✓ ✓ ✓
SDDizziness ✓ ✓ ✓
SDEpstein-Barr virus infection · · ✓
SDFatigue ✓ ✓ ✓
SDNeurological symptom ✓ ✓ ✓
SDOptic neuritis · · ✓
SDTransient ischaemic attack ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release